- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Isocytosine deaminase Vcz as a novel tool for the prodrug cancer therapy ; volume:19 ; number:1 ; day:4 ; month:3 ; year:2019 ; pages:1-11 ; date:12.2019
BMC cancer ; 19, Heft 1 (4.3.2019), 1-11, 12.2019
- Creator
-
Kazlauskas, Arunas
Darinskas, Adas
Meškys, Rolandas
Tamašauskas, Arimantas
Urbonavičius, Jaunius
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12885-019-5409-7
- URN
-
urn:nbn:de:101:1-2019033002114269736579
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:52 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kazlauskas, Arunas
- Darinskas, Adas
- Meškys, Rolandas
- Tamašauskas, Arimantas
- Urbonavičius, Jaunius
- SpringerLink (Online service)
Other Objects (12)
Engineering Extracellular Vesicles with the Tools of Enzyme Prodrug Therapy
CD95L pro-drug : a novel Swiss Army Knife in cancer therapy?
Targeted enzyme prodrug therapy for metastatic prostate cancer – a comparative study of L-methioninase, purine nucleoside phosphorylase, and cytosine deaminase
Novel glycosyl prodrug of RXP03 as MMP-11 prodrug: design, synthesis and virtual screening
Nanoparticulation of Prodrug into Medicines for Cancer Therapy
Novel Prodrug Strategies for the Treatment of Tuberculosis
Prodrug-conjugated tumor-seeking commensals for targeted cancer therapy
Glutathione‐Responsive Nanoparticles of Camptothecin Prodrug for Cancer Therapy
The cytidine deaminase under-representation reporter (CDUR) as a tool to study evolution of sequences under deaminase mutational pressure
Rational Design of Responsive Prodrug-based Nanomedicines for Antitumor Therapy
Dual-vector prodrug activator gene therapy using retroviral replicating vectors
Near-infrared light-triggered nano-prodrug for cancer gas therapy
Engineering Extracellular Vesicles with the Tools of Enzyme Prodrug Therapy
CD95L pro-drug : a novel Swiss Army Knife in cancer therapy?
Targeted enzyme prodrug therapy for metastatic prostate cancer – a comparative study of L-methioninase, purine nucleoside phosphorylase, and cytosine deaminase
Novel glycosyl prodrug of RXP03 as MMP-11 prodrug: design, synthesis and virtual screening
Nanoparticulation of Prodrug into Medicines for Cancer Therapy
Novel Prodrug Strategies for the Treatment of Tuberculosis
Prodrug-conjugated tumor-seeking commensals for targeted cancer therapy
Glutathione‐Responsive Nanoparticles of Camptothecin Prodrug for Cancer Therapy
The cytidine deaminase under-representation reporter (CDUR) as a tool to study evolution of sequences under deaminase mutational pressure
Rational Design of Responsive Prodrug-based Nanomedicines for Antitumor Therapy
Dual-vector prodrug activator gene therapy using retroviral replicating vectors
Near-infrared light-triggered nano-prodrug for cancer gas therapy
Engineering Extracellular Vesicles with the Tools of Enzyme Prodrug Therapy
CD95L pro-drug : a novel Swiss Army Knife in cancer therapy?
Targeted enzyme prodrug therapy for metastatic prostate cancer – a comparative study of L-methioninase, purine nucleoside phosphorylase, and cytosine deaminase
Novel glycosyl prodrug of RXP03 as MMP-11 prodrug: design, synthesis and virtual screening
Nanoparticulation of Prodrug into Medicines for Cancer Therapy
Novel Prodrug Strategies for the Treatment of Tuberculosis
Prodrug-conjugated tumor-seeking commensals for targeted cancer therapy
Glutathione‐Responsive Nanoparticles of Camptothecin Prodrug for Cancer Therapy
The cytidine deaminase under-representation reporter (CDUR) as a tool to study evolution of sequences under deaminase mutational pressure
Rational Design of Responsive Prodrug-based Nanomedicines for Antitumor Therapy
Dual-vector prodrug activator gene therapy using retroviral replicating vectors